Hemolytic disease of the fetus and newborn (HDFN) is due to passively transferred maternal antibodies directed against fetal red blood cell (RBC) antigens and can lead to severe morbidity and… Click to show full abstract
Hemolytic disease of the fetus and newborn (HDFN) is due to passively transferred maternal antibodies directed against fetal red blood cell (RBC) antigens and can lead to severe morbidity and mortality. Anti‐M is usually a naturally occurring antibody of low clinical significance, although occasionally severe cases of HDFN are seen.
               
Click one of the above tabs to view related content.